Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Rodger Elofson

Adolescent Medicine Baton Rouge, LA Medical Doctor

NPI 1700997103 CMS profile 696921

8040 Goodwood Blvd, Baton Rouge, LA 70806

Open in the dashboard

General payments

$949

65 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$105,242 paid to institutions, not to them · program years 2019–2020

Through program year 2025, Rodger Elofson of Baton Rouge, LA is reported in the CMS Open Payments database as having received $949 across 65 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $105,242 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 79th percentile of Adolescent Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $19 1
2022 General $15 1
2021 General $244 15
2020 General $207 13
2019 General $464 35

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Rodger Elofson
  • Adolescent Medicine median
  • Middle half of Adolescent Medicine
  • National median

In program year 2025, general payments to Rodger Elofson were reported at $19. Among 914 Adolescent Medicine profiles paid that year, the median was $100 and the middle half received between $40 and $207.

Show as a table
Year Rodger Elofson Adolescent Medicine median Middle half National median
2019 $464 $95 $36–$198 $163
2020 $207 $50 $23–$111 $114
2021 $244 $67 $27–$179 $132
2022 $15 $79 $29–$189 $149
2023 $0 $100 $39–$194 $160
2024 $0 $93 $38–$195 $164
2025 $19 $100 $40–$207 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Neos Therapeutics, LP $271 18 payments
  2. Tris Pharma Inc $254 16 payments
  3. Takeda Pharmaceuticals U.S.A., Inc. $126 7 payments
  4. Merck Sharp & Dohme Corporation $74 7 payments
  5. Ironshore Pharmaceuticals Inc. $41 2 payments
  6. Pfizer Inc. $30 5 payments
  7. kaleo, Inc. $30 2 payments
  8. Adlon Therapeutics L.P. $28 2 payments
  9. Supernus Pharmaceuticals, Inc. $21 1 payment
  10. GlaxoSmithKline, LLC. $18 1 payment
  11. Other $56 4 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $949 65 payments
Products named General payments · program years 2019–2025
  1. COTEMPLA XR-ODT $238 16 payments
  2. Adzenys XR-ODT Adhd $208 14 payments
  3. Quillivant XR $158 10 payments
  4. VYVANSE Neuroscience $82 5 payments
  5. Dyanavel XR $61 4 payments
  6. Adzenys XR-ODT Adhd $51 3 payments
  7. Vyvanse Central Nervous System (CNS) $44 2 payments
  8. Jornay PM 20mg capsules (Bottle of 100) $41 2 payments
  9. GARDASIL 9 $38 2 payments
  10. ROTATEQ $37 5 payments
  11. Other $365 30 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

65 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Adolescent Medicine in Louisiana

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record